PhD Research in Radiopharmaceuticals, KU Leuven, Belgium
Expires on: 03/05/2024 Description Embark on a transformative journey in cancer treatment research with the PhD opportunity in “Protein-based Chelators for Targeted Radionuclide Therapy.” This project, commencing March 5th, 2024, explores innovative approaches to enhance the development of radiopharmaceuticals for targeted cancer treatment. As a prospective candidate, you have the chance to contribute to groundbreaking […]
PhD Research in Radiopharmaceuticals, KU Leuven, Belgium Read More »